HTG MOLECULAR DIAGNOSTICS IN
Q2 2021 13F Holders
CUSIP
40434H203
Type
Equity
Class
COM NEW
Num filings
26
Total reported value, excl. options
$19.7 M
Compare 2021 Q2 to
2022 Q3
2022 Q2
2022 Q1
2021 Q4
2021 Q3
2021 Q1
2020 Q4
Manager
Report Date
Value ($000)
Shares
Option Type